CD44 Expression in Renal Tissue Is Associated with an Increase in Urinary Levels of Complement Components in Chronic Glomerulopathies

It is suggested that activated CD44+ cells play a profibrogenic role in the pathogenesis of active glomerulopathies. Complement activation is also involved in renal fibrogenesis. The aim of the study was to evaluate the role of the activation of CD44+ cells in the kidney tissue and complement components’ filtration to the urine as factors of renal tissue fibrosis in patients with glomerulopathies. In total, 60 patients with active glomerulopathies were included in our study: 29 patients with focal segmental glomerulosclerosis (FSGS), 10 patients with minimal change disease (MCD), 10 patients with membranous nephropathy (MN), and 11 patients with IgA nephropathy. The immunohistochemical peroxidase method was used to study the expression of CD44+ in kidney biopsies. Components of complement were analyzed in urine by the multiple reaction monitoring (MRM) approach using liquid chromatography. Strong CD44 expression was noted predominantly in PEC and mesangial cells (MC) in patients with FSGS, and to a lesser extent, in patients with MN and IgA nephropathy, and it was absent in patients with MCD. Expression of profibrogenic CD44+ in glomeruli correlated with the levels of proteinuria and complement C2, C3, and C9 components, and CFB and CFI in urine. The CD44+ expression scores in the renal interstitium correlated with the level of C3 and C9 components of complement in the urine and the area of tubulo-interstitial fibrosis. The strongest expression of CD44+ was found in the glomeruli (MC, PEC, and podocytes) of patients with FSGS compared with other glomerulopathies. The CD44 expression score in the glomeruli and interstitium is associated with high levels of complement components in the urine and renal fibrosis.

[1]  M. Indeykina,et al.  Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease , 2022, International journal of molecular sciences.

[2]  A. Bonnefoy,et al.  Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis , 2022, Kidney international reports.

[3]  J. A. van der Laak,et al.  Parietal epithelial cells maintain the epithelial cell continuum forming Bowman's space in focal segmental glomerulosclerosis , 2021, Disease models & mechanisms.

[4]  A. Bonnefoy,et al.  Clinical Use of Complement, Inflammation, and Fibrosis Biomarkers in Autoimmune Glomerulonephritis , 2020, Kidney international reports.

[5]  Ming-hui Zhao,et al.  Complement activation profile of patients with primary focal segmental glomerulosclerosis , 2020, PloS one.

[6]  S. Shankland,et al.  CD44 impacts glomerular parietal epithelial cell changes in the aged mouse kidney , 2020, Physiological reports.

[7]  C. Alpers,et al.  Differential Expression of Parietal Epithelial Cell and Podocyte Extracellular Matrix Proteins in Focal Segmental Glomerulosclerosis and Diabetic Nephropathy. , 2019, American journal of physiology. Renal physiology.

[8]  T. Ariga,et al.  CD44-Positive Glomerular Parietal Epithelial Cells in a Mouse Model of Calcineurin Inhibitors-Induced Nephrotoxicity , 2019, Nephron.

[9]  C. Zeng,et al.  Upregulated long noncoding RNA LOC105375913 induces tubulointerstitial fibrosis in focal segmental glomerulosclerosis , 2019, Scientific Reports.

[10]  E. Puré,et al.  CD44-dependent inflammation, fibrogenesis, and collagenolysis regulates extracellular matrix remodeling and tensile strength during cutaneous wound healing. , 2019, Matrix biology : journal of the International Society for Matrix Biology.

[11]  B. Smeets,et al.  CD44 is required for the pathogenesis of experimental crescentic glomerulonephritis and collapsing focal segmental glomerulosclerosis. , 2017, Kidney international.

[12]  Y. Kim,et al.  Potential urine proteomics biomarkers for primary nephrotic syndrome , 2017, Clinical Proteomics.

[13]  S. Shankland,et al.  Activated ERK1/2 increases CD44 in glomerular parietal epithelial cells leading to matrix expansion. , 2017, Kidney international.

[14]  Linda T. Senbanjo,et al.  CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells , 2017, Front. Cell Dev. Biol..

[15]  D. Gipson,et al.  Complement Activation in Patients with Focal Segmental Glomerulosclerosis , 2015, PloS one.

[16]  V. Lokeshwar,et al.  The Role of CD44 in Disease Pathophysiology and Targeted Treatment , 2015, Front. Immunol..

[17]  R. Zubarev,et al.  The Novel Diagnostic Biomarkers for Focal Segmental Glomerulosclerosis , 2014, International journal of nephrology.

[18]  E. B. Meltzer,et al.  Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44 , 2011, The Journal of experimental medicine.

[19]  B. Smeets,et al.  Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. , 2011, Journal of the American Society of Nephrology : JASN.

[20]  K. Chatila,et al.  CD44 Is Critically Involved in Infarct Healing by Regulating the Inflammatory and Fibrotic Response1 , 2008, The Journal of Immunology.

[21]  T. Sugisaki,et al.  Roles of and correlation between alpha-smooth muscle actin, CD44, hyaluronic acid and osteopontin in crescent formation in human glomerulonephritis. , 2005, Clinical nephrology.

[22]  A. Papagianni,et al.  Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  R. Wüthrich The proinflammatory role of hyaluronan-CD44 interactions in renal injury. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  S. Goodison,et al.  CD44 cell adhesion molecules. , 1999, Molecular pathology : MP.

[25]  N. Hotta,et al.  Complement activation products in the urine from proteinuric patients. , 1998, Journal of the American Society of Nephrology : JASN.

[26]  R. Atkins,et al.  CD44 and hyaluronan expression in the development of experimental crescentic glomerulonephritis , 1997, Clinical and experimental immunology.

[27]  R. Atkins,et al.  De novo CD44 expression by proliferating mesangial cells in rat anti-Thy-1 nephritis. , 1996, Journal of the American Society of Nephrology : JASN.

[28]  T. Glant,et al.  Anti-CD44 treatment abrogates tissue aedema and leukocyte infiltration in murine arthrtis , 1995, Nature Medicine.

[29]  W. Remmele,et al.  [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. , 1987, Der Pathologe.